Therapeutic agent
AssigneeMedella Therapeutics Ltd.
InventorsTimothy Michael Skerry, Gareth Owain Richards
Life of this patent
Estimating the term…
Abstract
The present invention relates to agents which modulate the effect of a RAMP (Receptor Activity Modifying Protein) protein on a Calcitonin Receptor Like Receptor (CRLR). Also included in the present invention are methods and uses of such agents and assays for identifying such agents. The agents of the present disclosure may be used in the treatment of, for example, cancer, obesity and other disorders.
Claims9
A method for inhibiting cancer cell proliferation in a subject in need thereof, comprising administering to the subject an effective amount of a pharmaceutical formulation comprising a monoclonal antibody, or an antigen-binding fragment thereof, that binds to the peptide of SEQ ID NO:
- 67 and a component selected from the group consisting of:
- pharmaceutically acceptable carriers, diluents and excipients.
A method for inhibiting cancer cell proliferation in a subject in need thereof, comprising administering to the subject an antibody, or antigen-binding fragment thereof, that binds to SEQ ID NO:
- 67.
Dependencies are inferred from the claim text.